Status:
WITHDRAWN
Calm for Cancer Patients Receiving Chemotherapy
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
Arizona State University
Conditions:
Cancer Colorectal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chemotherapy is a common strategy used to treat colorectal cancer patients, but is often leads patients and survivors to experience a host of symptoms, of which acute emotional distress is a major con...
Detailed Description
Chemotherapy is a common treatment modality among colorectal cancer patients. Despite improvements in survival among those receiving chemotherapy, patients often experience side effects including pain...
Eligibility Criteria
Inclusion
- Have a colorectal cancer diagnosis and waiting the beginning of adjuvant chemotherapy treatment at the Mays Cancer Center University of Texas (UT) Health San Antonio
- Own a mobile smartphone (iPhone with iOS 9.0 or later or an Android 4.1 or later)
- Willing to download a mobile app
- Able to read and understand English or Spanish
- Aged 18 years or older
- Willing to be randomized to one of two groups
Exclusion
- Meditation or meditative movement practice (i.e., yoga, tai chi, qigong) of greater than or equal to 60 min/month in the past six months
- Use of any consumer-based meditation app
- Reside outside of the united states
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04345952
Start Date
February 1 2022
End Date
December 1 2023
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78229